333 related articles for article (PubMed ID: 20164683)
1. Vitamin D: considerations in the continued development as an agent for cancer prevention and therapy.
Trump DL; Deeb KK; Johnson CS
Cancer J; 2010; 16(1):1-9. PubMed ID: 20164683
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D compounds: clinical development as cancer therapy and prevention agents.
Trump DL; Muindi J; Fakih M; Yu WD; Johnson CS
Anticancer Res; 2006; 26(4A):2551-6. PubMed ID: 16886663
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness and safety of vitamin D in relation to bone health.
Cranney A; Horsley T; O'Donnell S; Weiler H; Puil L; Ooi D; Atkinson S; Ward L; Moher D; Hanley D; Fang M; Yazdi F; Garritty C; Sampson M; Barrowman N; Tsertsvadze A; Mamaladze V
Evid Rep Technol Assess (Full Rep); 2007 Aug; (158):1-235. PubMed ID: 18088161
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D and cancer: clinical aspects.
Woloszynska-Read A; Johnson CS; Trump DL
Best Pract Res Clin Endocrinol Metab; 2011 Aug; 25(4):605-15. PubMed ID: 21872802
[TBL] [Abstract][Full Text] [Related]
5. Molecular basis of the potential of vitamin D to prevent cancer.
Ingraham BA; Bragdon B; Nohe A
Curr Med Res Opin; 2008 Jan; 24(1):139-49. PubMed ID: 18034918
[TBL] [Abstract][Full Text] [Related]
6. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
7. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
8. Interventions for metabolic bone disease in children with chronic kidney disease.
Hahn D; Hodson EM; Craig JC
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD008327. PubMed ID: 26561037
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D supplementation for prevention of cancer in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Krstic G; Wetterslev J; Gluud C
Cochrane Database Syst Rev; 2014 Jun; (6):CD007469. PubMed ID: 24953955
[TBL] [Abstract][Full Text] [Related]
10. The role of vitamin D in cancer prevention.
Ness RA; Miller DD; Li W
Chin J Nat Med; 2015 Jul; 13(7):481-97. PubMed ID: 26233839
[TBL] [Abstract][Full Text] [Related]
11. A Phase I trial of calcitriol (1,25-dihydroxycholecalciferol) in patients with advanced malignancy.
Smith DC; Johnson CS; Freeman CC; Muindi J; Wilson JW; Trump DL
Clin Cancer Res; 1999 Jun; 5(6):1339-45. PubMed ID: 10389917
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D-related therapies in prostate cancer.
Johnson CS; Hershberger PA; Trump DL
Cancer Metastasis Rev; 2002; 21(2):147-58. PubMed ID: 12465754
[TBL] [Abstract][Full Text] [Related]
13. The role of vitamin D in cancer prevention and treatment.
Krishnan AV; Trump DL; Johnson CS; Feldman D
Endocrinol Metab Clin North Am; 2010 Jun; 39(2):401-18, table of contents. PubMed ID: 20511060
[TBL] [Abstract][Full Text] [Related]
14. Alendronate sodium/vitamin D3 combination tablet versus calcitriol for osteoporosis in Chinese postmenopausal women: a 6-month, randomized, open-label, active-comparator-controlled study with a 6-month extension.
Zhang ZL; Liao EY; Xia WB; Lin H; Cheng Q; Wang L; Hao YQ; Chen DC; Tang H; De Peng Y; You L; He L; Hu ZH; Song CL; Wei F; Wang J; Zhang L; Santora AC
Osteoporos Int; 2015 Sep; 26(9):2365-74. PubMed ID: 25929192
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
[TBL] [Abstract][Full Text] [Related]
16. Weekly high-dose calcitriol and docetaxel in advanced prostate cancer.
Beer TM; Hough KM; Garzotto M; Lowe BA; Henner WD
Semin Oncol; 2001 Aug; 28(4 Suppl 15):49-55. PubMed ID: 11685729
[TBL] [Abstract][Full Text] [Related]
17. Discordant Health Implications and Molecular Mechanisms of Vitamin D in Clinical and Preclinical Studies of Prostate Cancer: A Critical Appraisal of the Literature Data.
Fendler A; Stephan C; Ralla B; Jung K
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791324
[TBL] [Abstract][Full Text] [Related]
18. Prevention of preneoplastic mammary lesion development by a novel vitamin D analogue, 1alpha-hydroxyvitamin D5.
Mehta RG; Moriarty RM; Mehta RR; Penmasta R; Lazzaro G; Constantinou A; Guo L
J Natl Cancer Inst; 1997 Feb; 89(3):212-8. PubMed ID: 9017001
[TBL] [Abstract][Full Text] [Related]
19. Development of weekly high-dose calcitriol based therapy for prostate cancer.
Beer TM
Urol Oncol; 2003; 21(5):399-405. PubMed ID: 14670552
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.
Maj E; Filip-Psurska B; Milczarek M; Psurski M; Kutner A; Wietrzyk J
Int J Oncol; 2018 Feb; 52(2):337-366. PubMed ID: 29345296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
